- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nanjing Leads Biolabs Co Ltd (9887)
Nanjing Leads Biolabs Co Ltd stock price live, this page displays HK 9887 stock exchange data. View the 9887 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nanjing Leads Biolabs Co Ltd real time stock price chart below.
What Is the Nanjing Leads Biolabs Co Ltd Stock Price Today?
The Nanjing Leads Biolabs Co Ltd stock price today is 63.30.
What Is the Stock Symbol for Nanjing Leads Biolabs Co Ltd?
The stock symbol for Nanjing Leads Biolabs Co Ltd is ""9887.""
What Stock Exchange Does Nanjing Leads Biolabs Co Ltd Trade On?
Nanjing Leads Biolabs Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Nanjing Leads Biolabs Co Ltd a Good Stock to Buy?
Determining whether Nanjing Leads Biolabs Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9887 quote. (ISIN: CNE1000070H8)
What Is the Nanjing Leads Biolabs Co Ltd Stock Price Today?
The Nanjing Leads Biolabs Co Ltd stock price today is 63.30.
What Is the Stock Symbol for Nanjing Leads Biolabs Co Ltd?
The stock symbol for Nanjing Leads Biolabs Co Ltd is ""9887.""
What Stock Exchange Does Nanjing Leads Biolabs Co Ltd Trade On?
Nanjing Leads Biolabs Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Nanjing Leads Biolabs Co Ltd a Good Stock to Buy?
Determining whether Nanjing Leads Biolabs Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9887 quote. (ISIN: CNE1000070H8)
Hong Kong
Currency in HKD
63.30
+0.60(+0.96%)
Delayed Data·
Fair Value
An estimate of a Nanjing Leads Biolabs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.25
63.30
52 wk Range
57.45
83.60
9887 Scorecard
Full Analysis
Stock generally trades with high price volatility
9887 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Nanjing Leads Biolabs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.2563.30
52 wk Range
57.4583.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
9887 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Nanjing Leads Biolabs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
76.66
Upside
+21.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Nanjing Leads Biolabs Co Ltd Company Profile
Nanjing Leads Biolabs Co., Ltd., a clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide. It develops therapies in oncology, autoimmune, and other severe diseases. The company’s lead product LBL-024, a PD-L1/4-1BB bispecific antibody for extra-pulmonary neuroendocrine carcinoma, as well as LBL-034, LBL-033, and LBL-007. In addition, it develops LeadsBody platform, a portfolio of CD3 T-cell engagers that demonstrate anti-tumor efficacy and safety in preclinical/clinical studies; X-body platform, a 4-1BB/PD-L1 bispecific antibody. The company also develops antibody drugs for anti-tumor, autoimmune and infectious diseases and establishes tumor immunoassay. The company was founded in 2012 and is headquartered in Nanjing, China.
Compare 9887 to Peers and Sector
Metrics to compare | 9887 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship9887PeersSector | |
|---|---|---|---|---|
P/E Ratio | −39.7x | −36.8x | −0.7x | |
PEG Ratio | - | −0.43 | 0.00 | |
Price/Book | 108.6x | 6.3x | 2.6x | |
Price / LTM Sales | - | 18.9x | 3.4x | |
Upside (Analyst Target) | 27.9% | 38.3% | 38.2% | |
Fair Value Upside | Unlock | −13.9% | 4.7% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 76.66
(+21.10% Upside)
Earnings
Latest Release
Aug 29, 2025
EPS / Forecast
-0.58 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Nanjing Leads Biolabs Trade On?
Nanjing Leads Biolabs is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Nanjing Leads Biolabs?
The stock symbol for Nanjing Leads Biolabs is "9887."
What Is the Nanjing Leads Biolabs Market Cap?
As of today, Nanjing Leads Biolabs market cap is 12.47B.
What Is Nanjing Leads Biolabs's Earnings Per Share (TTM)?
The Nanjing Leads Biolabs EPS (TTM) is -1.86.
From a Technical Analysis Perspective, Is 9887 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nanjing Leads Biolabs Stock Split?
Nanjing Leads Biolabs has split 0 times.
How Many Employees Does Nanjing Leads Biolabs Have?
Nanjing Leads Biolabs has 192 employees.
What is the current trading status of Nanjing Leads Biolabs (9887)?
As of 24 Oct 2025, Nanjing Leads Biolabs (9887) is trading at a price of 63.30, with a previous close of 62.70. The stock has fluctuated within a day range of 62.25 to 63.30, while its 52-week range spans from 57.45 to 83.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.